Status Epilepticus in the Critically Ill Patients
- Conditions
- Status Epilepticus
- Registration Number
- NCT03457831
- Lead Sponsor
- Ictal Group
- Brief Summary
Convulsive and Non Convulsive Status Epilepticus (SE) and Pseudo Status Epilepticus prospective registry.
Data collection using a standardized form : demographic data and data related to the SE, including circumstances of onset, dates and times of onset and of seizure control, on-scene clinical findings, clinical features of the seizures, pre-hospital and hospital care providers, timing of antiepileptic and supportive treatments, results of etiological investigations, cause of SE, type and dosage of antiepileptic drugs. Dates and times of EEG monitoring, EEG results. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- SE defined as 5 min or more of (i) continuous clinical and/or electrographic seizure activity or (ii) recurrent seizure activity without recovery (returning to baseline) between seizures.
- age >= 18 years
- age < 18 years
- postanoxic status epilepticus
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Favorable outcome 1 year A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined according to patients charts review and/or general practitioner interview conducted by an independent assessor. The GOS score : \[1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability\]
- Secondary Outcome Measures
Name Time Method percentages of the patients that experience recurrent convulsive and/or non-convulsive seizures within 12 hours after ICU admission 12 hours refractory status epilepticus 24 hours super refractory status epilepticus 72 hours total ICU and in-hospital length of stay 90 days total ICU and in-hospital length of stay in days
mortality rate ICU and hospital discharge, 3-months, and 1-year, 5 years and 10 years Favorable outcome 3 months, 5-years and 10 years A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined patients charts review and/or general practitioner interview conducted by an independent assessor. The GOS score : \[1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability\]
Functional impairment 3 months, and 1-year, 5-years and 10-years Percentages of the patients that experience functional impairment (motor, sensitive, cognitive, epilepsy)
total seizure duration 72 hours total seizure duration in minutes
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (20)
CH Angouleme - Service de réanimation polyvalente
🇫🇷Angoulême, France
CH de Beauvais - Service de réanimation polyvalente
🇫🇷Beauvais, France
CH de Bethune - Service de Réanimation et Surveillance continue
🇫🇷Beuvry, France
Centre Hospitalier Universitaire Régional
🇫🇷Brest, France
CH Brive La Gaillarde - Service de réanimation - USC
🇫🇷Brive-la-Gaillarde, France
CH de Cannes
🇫🇷Cannes, France
CH Public du Cotentin - Service de Réanimation - Médecin intensive
🇫🇷Cherbourg, France
CHU Beaujon
🇫🇷Clichy, France
Hopitaux Universitaires Henri Mondor - Service d'anesthésie et des réanimations chirurgicales, Unité d'anesthésie-réanimation chirurgical cardiovasculaire
🇫🇷Créteil, France
Centre Hospitalier de Dieppe
🇫🇷Dieppe, France
Scroll for more (10 remaining)CH Angouleme - Service de réanimation polyvalente🇫🇷Angoulême, FranceDavid SCHNELL, MDPrincipal Investigator